Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
The Pediatric Infectious Disease Journal|March 8, 2005
Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old childrenJavier Diez-Domingo, Javier Díez Delgado, Alfredo Ballester, et al.
Diabetes Research and Clinical Practice|May 29, 2017
Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary careMaría Cristo Rodríguez-Pérez, Domingo Orozco-Beltrán, Vicente Gil-Guillén, et al.
BMC Public Health|June 7, 2013
Prevalence of obesity and associated cardiovascular risk: the DARIOS studyFrancisco Javier Félix-Redondo, María Grau, José Miguel Baena-Díez, et al.
Scientific Reports|September 28, 2022
Developing CIRdb as a catalog of natural genetic variation in the Canary IslandersAna Díaz-de Usera, Luis A Rubio-Rodríguez, Adrián Muñoz-Barrera, et al.
Diabetes Research and Clinical Practice|November 8, 2015
On the problem of type 2 diabetes-related mortality in the Canary Islands, Spain. The DARIOS StudyItahisa Marcelino-Rodríguez, Roberto Elosua, María del Cristo Rodríguez Pérez, et al.
Revista Espanola De Cardiologia|July 19, 2011
[Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study]José Miguel Baena-Díez, Francisco Javier Félix, María Grau, et al.
Vaccines|November 11, 2022
Nanoformulations with <i>Leishmania braziliensis</i> Antigens Triggered Controlled Parasite Burden in Vaccinated Golden Hamster (<i>Mesocricetus auratus</i>) against Visceral LeishmaniasisJennifer Ottino, Jaqueline Costa Leite, Otoni Alves Melo-Júnior, et al.
Vaccines|January 21, 2023
Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in HamsterMarco Antonio Cabrera González, Ana Alice Maia Gonçalves, Jennifer Ottino, et al.
Plos One|July 7, 2012
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndromeClaire Meyniel, Timothy Spelman, Vilija G Jokubaitis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 7, 2014
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosisTomas Kalincik, Vilija Jokubaitis, Guillermo Izquierdo, et al.
Pageof 14